US 9604944
Arylpiperazine derivatives and methods of utilizing same
granted A61KA61K31/538A61P
Quick answer
US patent 9604944 (Arylpiperazine derivatives and methods of utilizing same) held by REVIVA PHARMACEUTICALS, INC. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/538, A61P, A61P25/00, A61P25/18